Portfolio Holdings Detail for ISIN IE00BGPP8L80
Stock Name / Fund iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF Ticker WMVG(GBP) LSE
ETF Ticker WMVG.L(GBP) LSE

Holdings detail for BMRN

Stock Name	Biomarin Pharmaceutical Inc
Ticker	BMRN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US09061G1013
LEI	NSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright: HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout: In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.: Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price: BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average: In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts: Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET: (RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC: Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00: BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.: Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.: Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.: Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025: It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) BMRN holdings

Date	Number of BMRN Shares Held	Base Market Value of BMRN Shares	Local Market Value of BMRN Shares	Change in BMRN Shares Held	Change in BMRN Base Value	Current Price per BMRN Share Held	Previous Price per BMRN Share Held
2025-11-12 (Wednesday)	52,521	USD 2,905,462	USD 2,905,462	0	USD 20,483	USD 55.32	USD 54.93
2025-11-11 (Tuesday)	52,521	USD 2,884,979	USD 2,884,979	0	USD 118,698	USD 54.93	USD 52.67
2025-11-10 (Monday)	52,521	USD 2,766,281	USD 2,766,281	0	USD 63,550	USD 52.67	USD 51.46
2025-11-07 (Friday)	52,521	USD 2,702,731	USD 2,702,731	0	USD -19,958	USD 51.46	USD 51.84
2025-11-06 (Thursday)	52,521	USD 2,722,689	USD 2,722,689	0	USD -50,420	USD 51.84	USD 52.8
2025-11-05 (Wednesday)	52,521	USD 2,773,109	USD 2,773,109	0	USD 14,706	USD 52.8	USD 52.52
2025-11-04 (Tuesday)	52,521	USD 2,758,403	USD 2,758,403	-530	USD -45,342	USD 52.52	USD 52.85
2025-11-03 (Monday)	53,051	USD 2,803,745	USD 2,803,745	0	USD -38,197	USD 52.85	USD 53.57
2025-10-31 (Friday)	53,051	USD 2,841,942	USD 2,841,942	251	USD 101,094	USD 53.57	USD 51.91
2025-10-30 (Thursday)	52,800	USD 2,740,848	USD 2,740,848	0	USD 2,640	USD 51.91	USD 51.86
2025-10-29 (Wednesday)	52,800	USD 2,738,208	USD 2,738,208	0	USD -86,064	USD 51.86	USD 53.49
2025-10-28 (Tuesday)	52,800	USD 2,824,272	USD 2,824,272	-504	USD 16,750	USD 53.49	USD 52.67
2025-10-27 (Monday)	53,304	USD 2,807,522	USD 2,807,522	0	USD -96,480	USD 52.67	USD 54.48

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00BGPP8L80

Show aggregate share trades of BMRN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-04 SELL -530 52.760 51.800 51.896 USD -27,505 61.84 Profit of 5,269 on sale
2025-10-31 BUY 251 53.620 51.020 51.280 USD 12,871 61.92
2025-10-28 SELL -504 53.490 56.800 56.469 USD -28,460 62.06 Profit of 2,816 on sale
2025-10-21 SELL -500 53.810 53.980 53.963 USD -26,981 62.26 Profit of 4,149 on sale
2025-10-14 SELL -251 52.470 52.810 52.776 USD -13,247 62.49 Profit of 2,439 on sale
2025-10-02 SELL -996 55.570 55.990 55.948 USD -55,724 62.60 Profit of 6,627 on sale
2025-09-25 SELL -250 52.620 54.500 54.312 USD -13,578 62.83 Profit of 2,130 on sale
2025-09-09 SELL -542 55.690 56.500 56.419 USD -30,579 63.04 Profit of 3,588 on sale
2025-07-28 SELL -428 58.140 59.400 59.274 USD -25,369 63.40 Profit of 1,768 on sale
2025-07-15 SELL -1,576 56.620 58.670 58.465 USD -92,141 63.57 Profit of 8,040 on sale
2025-07-11 SELL -788 58.100 58.500 58.460 USD -46,066 63.63 Profit of 4,075 on sale
2025-07-02 BUY 394 57.170 57.610 57.566 USD 22,681 63.88
2025-06-30 SELL -1,194 54.970 55.960 55.861 USD -66,698 63.94 Profit of 9,641 on sale
2025-06-27 SELL -1,326 55.170 55.200 55.197 USD -73,191 63.99 Profit of 11,662 on sale
2025-06-26 BUY 396 54.100 54.550 54.505 USD 21,584 64.06
2025-06-25 SELL -398 54.140 54.610 54.563 USD -21,716 64.12 Profit of 3,803 on sale
2025-06-23 SELL -1,206 54.080 56.000 55.808 USD -67,304 64.25 Profit of 10,177 on sale
2025-06-20 SELL -403 55.000 56.250 56.125 USD -22,618 64.31 Profit of 3,297 on sale
2025-06-16 SELL -4,072 56.240 56.510 56.483 USD -229,999 64.55 Profit of 32,837 on sale
2025-06-13 SELL -397 56.220 57.360 57.246 USD -22,727 64.60 Profit of 2,921 on sale
2025-06-12 SELL -794 57.280 57.650 57.613 USD -45,745 64.65 Profit of 5,590 on sale
2025-06-11 SELL -1,985 57.160 57.990 57.907 USD -114,945 64.71 Profit of 13,495 on sale
2025-06-09 SELL -397 56.880 57.460 57.402 USD -22,789 64.81 Profit of 2,941 on sale
2025-05-30 SELL -393 58.070 58.480 58.439 USD -22,967 65.17 Profit of 2,644 on sale
2025-05-28 SELL -391 58.090 59.120 59.017 USD -23,076 65.27 Profit of 2,445 on sale
2025-05-21 SELL -391 58.480 59.510 59.407 USD -23,228 65.55 Profit of 2,402 on sale
2025-05-14 SELL -5,122 58.700 60.030 59.897 USD -306,792 65.81 Profit of 30,279 on sale
2025-05-09 BUY 2,015 58.860 60.660 60.480 USD 121,867 65.95
2025-05-07 SELL -1,556 59.320 60.160 60.076 USD -93,478 66.06 Profit of 9,308 on sale
2025-05-01 BUY 389 62.710 63.620 63.529 USD 24,713 66.21
2025-04-29 SELL -4,246 63.280 64.080 64.000 USD -271,744 66.26 Profit of 9,591 on sale
2025-04-28 BUY 5,201 62.980 63.870 63.781 USD 331,725 66.29
2025-04-25 BUY 374 63.300 63.440 63.426 USD 23,721 66.31
2025-04-23 BUY 1,245 61.940 63.390 63.245 USD 78,740 66.39
2025-04-22 BUY 3,384 61.500 61.530 61.527 USD 208,207 66.43
2025-04-15 SELL -1,128 60.020 60.930 60.839 USD -68,626 66.70 Profit of 6,615 on sale
2025-04-14 BUY 2,014 59.670 59.990 59.958 USD 120,755 66.77
2025-04-11 BUY 1,900 56.820 57.000 56.982 USD 108,266 66.87
2025-04-09 SELL -1,122 59.430 59.880 59.835 USD -67,135 67.05 Profit of 8,091 on sale
2025-04-08 SELL -1,496 55.890 61.070 60.552 USD -90,586 67.16 Profit of 9,882 on sale
2025-04-07 SELL -374 59.160 60.610 60.465 USD -22,614 67.24 Profit of 2,533 on sale
2025-04-04 BUY 376 60.260 66.490 65.867 USD 24,766 67.31
2025-04-01 BUY 1,500 67.940 70.630 70.361 USD 105,541 67.29
2025-03-27 SELL -754 72.830 73.180 73.145 USD -55,151 67.15 Loss of -4,519 on sale
2025-03-21 SELL -376 71.240 72.060 71.978 USD -27,064 66.95 Loss of -1,889 on sale
2025-03-14 BUY 1,134 69.440 70.410 70.313 USD 79,735 66.71
2025-03-13 BUY 378 70.600 71.930 71.797 USD 27,139 66.66
2025-03-12 BUY 756 70.540 70.820 70.792 USD 53,519 66.61
2025-03-11 BUY 756 70.490 72.350 72.164 USD 54,556 66.57
2025-03-10 SELL -377 72.030 72.990 72.894 USD -27,481 66.50 Loss of -2,412 on sale
2025-03-07 BUY 6,426 72.230 73.510 73.382 USD 471,553 66.42
2025-03-05 BUY 1,880 71.190 71.470 71.442 USD 134,311 66.36
2025-03-04 BUY 752 70.510 71.580 71.473 USD 53,748 66.31
2025-03-03 BUY 1,504 71.020 71.700 71.632 USD 107,735 66.25
2025-02-27 BUY 376 69.120 70.070 69.975 USD 26,311 66.14
2025-02-26 BUY 2,992 68.810 71.300 71.051 USD 212,585 66.11
2025-02-25 BUY 746 71.170 71.580 71.539 USD 53,368 66.04
2025-02-20 BUY 1,122 68.730 70.500 70.323 USD 78,902 65.92
2025-02-05 BUY 371 64.190 64.530 64.496 USD 23,928 66.18
2025-02-04 BUY 371 62.870 63.530 63.464 USD 23,545 66.24
2025-01-31 SELL -372 63.360 64.330 64.233 USD -23,895 66.36 Profit of 792 on sale
2025-01-30 BUY 372 63.880 64.230 64.195 USD 23,881 66.41
2025-01-29 SELL -371 63.460 64.050 63.991 USD -23,741 66.46 Profit of 918 on sale
2025-01-28 BUY 744 63.250 63.480 63.457 USD 47,212 66.53
2025-01-27 SELL -372 61.800 63.150 63.015 USD -23,442 66.62 Profit of 1,341 on sale
2024-12-10 SELL -379 66.430 67.070 67.006 USD -25,395 66.82 Loss of -72 on sale
2024-12-03 SELL -758 63.190 65.130 64.936 USD -49,221 66.93 Profit of 1,508 on sale
2024-11-29 SELL -379 66.030 66.170 66.156 USD -25,073 66.99 Profit of 317 on sale
2024-11-22 SELL -1,137 64.260 64.460 64.440 USD -73,268 67.34 Profit of 3,294 on sale
2024-11-05 SELL -3,024 66.040 66.230 66.211 USD -200,222 68.67 Profit of 7,423 on sale
2024-11-05 SELL -3,024 66.040 66.230 66.211 USD -200,222 68.67 Profit of 7,423 on sale
2024-10-29 BUY 377 69.910 70.560 70.495 USD 26,577 70.16
2024-10-29 BUY 377 69.910 70.560 70.495 USD 26,577 70.16
2024-10-24 BUY 377 70.390 70.980 70.921 USD 26,737 70.26
2024-10-24 BUY 377 70.390 70.980 70.921 USD 26,737 70.26
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-04	SELL	-530	52.760	51.800	51.896	USD -27,505	61.84 Profit of 5,269 on sale
2025-10-31	BUY	251	53.620	51.020	51.280	USD 12,871	61.92
2025-10-28	SELL	-504	53.490	56.800	56.469	USD -28,460	62.06 Profit of 2,816 on sale
2025-10-21	SELL	-500	53.810	53.980	53.963	USD -26,981	62.26 Profit of 4,149 on sale
2025-10-14	SELL	-251	52.470	52.810	52.776	USD -13,247	62.49 Profit of 2,439 on sale
2025-10-02	SELL	-996	55.570	55.990	55.948	USD -55,724	62.60 Profit of 6,627 on sale
2025-09-25	SELL	-250	52.620	54.500	54.312	USD -13,578	62.83 Profit of 2,130 on sale
2025-09-09	SELL	-542	55.690	56.500	56.419	USD -30,579	63.04 Profit of 3,588 on sale
2025-07-28	SELL	-428	58.140	59.400	59.274	USD -25,369	63.40 Profit of 1,768 on sale
2025-07-15	SELL	-1,576	56.620	58.670	58.465	USD -92,141	63.57 Profit of 8,040 on sale
2025-07-11	SELL	-788	58.100	58.500	58.460	USD -46,066	63.63 Profit of 4,075 on sale
2025-07-02	BUY	394	57.170	57.610	57.566	USD 22,681	63.88
2025-06-30	SELL	-1,194	54.970	55.960	55.861	USD -66,698	63.94 Profit of 9,641 on sale
2025-06-27	SELL	-1,326	55.170	55.200	55.197	USD -73,191	63.99 Profit of 11,662 on sale
2025-06-26	BUY	396	54.100	54.550	54.505	USD 21,584	64.06
2025-06-25	SELL	-398	54.140	54.610	54.563	USD -21,716	64.12 Profit of 3,803 on sale
2025-06-23	SELL	-1,206	54.080	56.000	55.808	USD -67,304	64.25 Profit of 10,177 on sale
2025-06-20	SELL	-403	55.000	56.250	56.125	USD -22,618	64.31 Profit of 3,297 on sale
2025-06-16	SELL	-4,072	56.240	56.510	56.483	USD -229,999	64.55 Profit of 32,837 on sale
2025-06-13	SELL	-397	56.220	57.360	57.246	USD -22,727	64.60 Profit of 2,921 on sale
2025-06-12	SELL	-794	57.280	57.650	57.613	USD -45,745	64.65 Profit of 5,590 on sale
2025-06-11	SELL	-1,985	57.160	57.990	57.907	USD -114,945	64.71 Profit of 13,495 on sale
2025-06-09	SELL	-397	56.880	57.460	57.402	USD -22,789	64.81 Profit of 2,941 on sale
2025-05-30	SELL	-393	58.070	58.480	58.439	USD -22,967	65.17 Profit of 2,644 on sale
2025-05-28	SELL	-391	58.090	59.120	59.017	USD -23,076	65.27 Profit of 2,445 on sale
2025-05-21	SELL	-391	58.480	59.510	59.407	USD -23,228	65.55 Profit of 2,402 on sale
2025-05-14	SELL	-5,122	58.700	60.030	59.897	USD -306,792	65.81 Profit of 30,279 on sale
2025-05-09	BUY	2,015	58.860	60.660	60.480	USD 121,867	65.95
2025-05-07	SELL	-1,556	59.320	60.160	60.076	USD -93,478	66.06 Profit of 9,308 on sale
2025-05-01	BUY	389	62.710	63.620	63.529	USD 24,713	66.21
2025-04-29	SELL	-4,246	63.280	64.080	64.000	USD -271,744	66.26 Profit of 9,591 on sale
2025-04-28	BUY	5,201	62.980	63.870	63.781	USD 331,725	66.29
2025-04-25	BUY	374	63.300	63.440	63.426	USD 23,721	66.31
2025-04-23	BUY	1,245	61.940	63.390	63.245	USD 78,740	66.39
2025-04-22	BUY	3,384	61.500	61.530	61.527	USD 208,207	66.43
2025-04-15	SELL	-1,128	60.020	60.930	60.839	USD -68,626	66.70 Profit of 6,615 on sale
2025-04-14	BUY	2,014	59.670	59.990	59.958	USD 120,755	66.77
2025-04-11	BUY	1,900	56.820	57.000	56.982	USD 108,266	66.87
2025-04-09	SELL	-1,122	59.430	59.880	59.835	USD -67,135	67.05 Profit of 8,091 on sale
2025-04-08	SELL	-1,496	55.890	61.070	60.552	USD -90,586	67.16 Profit of 9,882 on sale
2025-04-07	SELL	-374	59.160	60.610	60.465	USD -22,614	67.24 Profit of 2,533 on sale
2025-04-04	BUY	376	60.260	66.490	65.867	USD 24,766	67.31
2025-04-01	BUY	1,500	67.940	70.630	70.361	USD 105,541	67.29
2025-03-27	SELL	-754	72.830	73.180	73.145	USD -55,151	67.15 Loss of -4,519 on sale
2025-03-21	SELL	-376	71.240	72.060	71.978	USD -27,064	66.95 Loss of -1,889 on sale
2025-03-14	BUY	1,134	69.440	70.410	70.313	USD 79,735	66.71
2025-03-13	BUY	378	70.600	71.930	71.797	USD 27,139	66.66
2025-03-12	BUY	756	70.540	70.820	70.792	USD 53,519	66.61
2025-03-11	BUY	756	70.490	72.350	72.164	USD 54,556	66.57
2025-03-10	SELL	-377	72.030	72.990	72.894	USD -27,481	66.50 Loss of -2,412 on sale
2025-03-07	BUY	6,426	72.230	73.510	73.382	USD 471,553	66.42
2025-03-05	BUY	1,880	71.190	71.470	71.442	USD 134,311	66.36
2025-03-04	BUY	752	70.510	71.580	71.473	USD 53,748	66.31
2025-03-03	BUY	1,504	71.020	71.700	71.632	USD 107,735	66.25
2025-02-27	BUY	376	69.120	70.070	69.975	USD 26,311	66.14
2025-02-26	BUY	2,992	68.810	71.300	71.051	USD 212,585	66.11
2025-02-25	BUY	746	71.170	71.580	71.539	USD 53,368	66.04
2025-02-20	BUY	1,122	68.730	70.500	70.323	USD 78,902	65.92
2025-02-05	BUY	371	64.190	64.530	64.496	USD 23,928	66.18
2025-02-04	BUY	371	62.870	63.530	63.464	USD 23,545	66.24
2025-01-31	SELL	-372	63.360	64.330	64.233	USD -23,895	66.36 Profit of 792 on sale
2025-01-30	BUY	372	63.880	64.230	64.195	USD 23,881	66.41
2025-01-29	SELL	-371	63.460	64.050	63.991	USD -23,741	66.46 Profit of 918 on sale
2025-01-28	BUY	744	63.250	63.480	63.457	USD 47,212	66.53
2025-01-27	SELL	-372	61.800	63.150	63.015	USD -23,442	66.62 Profit of 1,341 on sale
2024-12-10	SELL	-379	66.430	67.070	67.006	USD -25,395	66.82 Loss of -72 on sale
2024-12-03	SELL	-758	63.190	65.130	64.936	USD -49,221	66.93 Profit of 1,508 on sale
2024-11-29	SELL	-379	66.030	66.170	66.156	USD -25,073	66.99 Profit of 317 on sale
2024-11-22	SELL	-1,137	64.260	64.460	64.440	USD -73,268	67.34 Profit of 3,294 on sale
2024-11-05	SELL	-3,024	66.040	66.230	66.211	USD -200,222	68.67 Profit of 7,423 on sale
2024-11-05	SELL	-3,024	66.040	66.230	66.211	USD -200,222	68.67 Profit of 7,423 on sale
2024-10-29	BUY	377	69.910	70.560	70.495	USD 26,577	70.16
2024-10-29	BUY	377	69.910	70.560	70.495	USD 26,577	70.16
2024-10-24	BUY	377	70.390	70.980	70.921	USD 26,737	70.26
2024-10-24	BUY	377	70.390	70.980	70.921	USD 26,737	70.26

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	410,026	8,500	779,513	52.6%
2025-09-18	309,934	9,272	546,271	56.7%
2025-09-17	792,001	76	1,198,919	66.1%
2025-09-16	481,505	0	1,174,969	41.0%
2025-09-15	537,109	68	901,192	59.6%
2025-09-12	559,519	41	804,638	69.5%
2025-09-11	479,992	858	740,032	64.9%
2025-09-10	670,394	301	865,419	77.5%
2025-09-09	347,787	0	583,412	59.6%
2025-09-08	440,427	0	726,535	60.6%
2025-09-05	291,870	0	466,536	62.6%
2025-09-04	516,779	0	829,878	62.3%
2025-09-03	280,802	0	490,768	57.2%
2025-09-02	312,757	0	686,202	45.6%
2025-08-29	214,126	13	370,043	57.9%
2025-08-28	251,916	7	439,795	57.3%
2025-08-27	370,349	6	578,905	64.0%
2025-08-26	289,675	233	549,904	52.7%
2025-08-25	355,827	100	585,453	60.8%
2025-08-22	357,184	16	556,528	64.2%
2025-08-21	352,501	1,525	524,293	67.2%
2025-08-20	339,777	74	602,589	56.4%
2025-08-19	220,437	0	499,041	44.2%
2025-08-18	330,939	435	644,696	51.3%
2025-08-15	498,822	0	931,913	53.5%
2025-08-14	241,436	0	529,668	45.6%
2025-08-13	719,992	350	1,132,112	63.6%
2025-08-12	217,242	4	606,989	35.8%
2025-08-11	336,985	0	722,604	46.6%
2025-08-08	574,538	39	1,320,708	43.5%
2025-08-07	387,504	31	837,240	46.3%
2025-08-06	571,718	43	896,314	63.8%
2025-08-05	1,685,687	12,503	3,542,200	47.6%
2025-08-04	1,579,757	0	3,686,257	42.9%
2025-08-01	716,526	0	2,200,777	32.6%
2025-07-31	549,459	38	925,084	59.4%
2025-07-30	718,573	10	1,234,755	58.2%
2025-07-29	226,725	75	481,375	47.1%
2025-07-28	243,626	5	412,929	59.0%
2025-07-25	247,295	86	445,587	55.5%
2025-07-24	380,699	137	586,872	64.9%
2025-07-23	251,713	0	450,219	55.9%
2025-07-22	387,886	114	638,283	60.8%
2025-07-21	228,375	6,803	346,208	66.0%
2025-07-18	292,003	100	575,028	50.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.